Skip to main content
Jeffery Taubenberger, MD, Pathology, Bethesda, MD

JefferyKTaubenbergerMDPhD

Pathology Bethesda, MD

Microbiology, Molecular Genetics, Anatomic Pathology, Surgical Pathology

Chief, Viral Pathogenesis and Evolution Section, NIAID, NIH

Dr. Taubenberger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Taubenberger's full profile

Already have an account?

  • Office

    33 North Drive, MSC 3203
    NIAID, NIH
    Bethesda, MD 20892
    Phone+1 301-761-6453
    Fax+1 301-480-1696

Education & Training

  • Virginia Commonwealth University
    Virginia Commonwealth UniversityPh.D., Anatomy, 1982 - 1987
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1986
  • George Mason University
    George Mason UniversityBS, Biology, 1979 - 1982

Certifications & Licensure

  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Molecular Genetic Pathology

Awards, Honors, & Recognition

  • Elected Member Association of American Physicians
  • Elected Member American Academy of Microbiology
  • 2008 University Alumnus of the Year George Mason University, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses  
    Jeffery Taubenberger, MD, mBio

Press Mentions

  • American Institute to Test Universal Flu Vaccine
    American Institute to Test Universal Flu VaccineJuly 12th, 2022
  • Here We Go: NIH Begins Testing Phase I Clinical Trial of Universal Flu Vaccine
    Here We Go: NIH Begins Testing Phase I Clinical Trial of Universal Flu VaccineJuly 1st, 2022
  • Universal Influenza Vaccine, Developed at NIAID, Starts Clinical Trial
    Universal Influenza Vaccine, Developed at NIAID, Starts Clinical TrialJune 29th, 2022
  • Join now to see all

Grant Support

  • H1N1 Influenza Comparative PathogenesisNational Institute Of Allergy And Infectious Diseases2011
  • H1N1 Influenza Clinical ResearchNational Institute Of Allergy And Infectious Diseases2011
  • Influenza Viral PathogenesisNational Institute Of Allergy And Infectious Diseases2009–2011
  • Influenza Viral Genomics And EvolutionNational Institute Of Allergy And Infectious Diseases2009–2011
  • Analysis Of Historical Influenza VirusesNational Institute Of Allergy And Infectious Diseases2009–2011
  • Arra [Unreadable]H1n1 Influenza Clinical ResearchNational Institute Of Allergy And Infectious Diseases2009–2010
  • Arra [Unreadable] H1N1 Influenza Comparative PathogenesisNational Institute Of Allergy And Infectious Diseases2009–2010
  • Influenza Viral PathogenesisNational Institute Of Allergy And Infectious Diseases2007–2008
  • Influenza Viral Genomics And EvolutionNational Institute Of Allergy And Infectious Diseases2007–2008
  • Analysis Of Historical Influenza VirusesNational Institute Of Allergy And Infectious Diseases2007–2008
  • Viral And Host CDNA Libraries From 1918 Influenza CasesNational Institute Of Allergy And Infectious Diseases2004–2008
  • Complete Characterization Of The 1918 Influenza VirusNational Institute Of Allergy And Infectious Diseases2002–2006
  • Thymic Epithelial Cell Induced Prothymocyte MigrationNational Institute On Aging1986

Other Languages

  • German